The effect of filgrastim and pegfilgrastim in the treatment of fever and immune deficiency
Phase 1
- Conditions
- Ischemic stroke.Cerebral infarction
- Registration Number
- IRCT20130812014333N80
- Lead Sponsor
- Vice chancellor for research, Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Patients with leukemia, suffering from fever and neutropenia (NAC less than 1500)
Exclusion Criteria
Neutropenic patients other than leukemia
patients who have not received the full course of treatment
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fever. Timepoint: At the beginning of the study, every other day until fever is stopped. Method of measurement: Using the Thermometer.;Neutropenia. Timepoint: At the beginning of the study, every other day until the ANC reaches over 1500. Method of measurement: Based on laboratory kits and based on the results of blood tests.
- Secondary Outcome Measures
Name Time Method